NEW YORK (AP) — Valeant Pharmaceuticals CEO J. Michael Pearson is taking a medical leave of absence after he was hospitalized with pneumonia last week.
Shares of the troubled Canadian pharmaceutical company fell 7 percent in premarket trading Monday.
Pearson’s leave comes two weeks after Valeant Pharmaceuticals International Inc. slashed its fourth-quarter financial predictions and issued a profit outlook for 2016 that was short of Wall Street’s estimate. Its sales have been hurt after ending a distribution arrangement with mail-order pharmacy Philidor, following scrutiny from Congress and the media.
Valeant says three executives will take over for Pearson in his absence.
COMMENTS
Please let us know if you're having issues with commenting.